ClinVar Miner

Submissions for variant NM_000053.4(ATP7B):c.3369G>A (p.Pro1123=) (rs61733679)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000588949 SCV000883433 likely benign not provided 2018-05-25 criteria provided, single submitter clinical testing The ATP7B c.3369G>A; p.Pro1123Pro variant (rs61733679), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 92388). This variant is found in the general population with an overall allele frequency of 0.1% (330/277178 alleles) in the Genome Aggregation Database, with an increased frequency of 1.2% in African Americans. This is a synonymous variant in a weakly conserved nucleotide, and computational analyses (Alamut v.2.11) predict that this variant does not alter splicing. Based on available information, this variant is considered to be likely benign.
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000078050 SCV000109888 benign not specified 2013-02-26 criteria provided, single submitter clinical testing
GeneDx RCV000078050 SCV000726134 likely benign not specified 2018-01-12 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Illumina Clinical Services Laboratory,Illumina RCV000302449 SCV000384657 uncertain significance Wilson disease 2016-06-14 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000588949 SCV000694445 likely benign not provided 2016-06-15 criteria provided, single submitter clinical testing Variant summary: The ATP7B c.3369G>A (p.Pro1123Pro) variant causes a synonymous change involving a non-conserved nucleotide with 4/5 splice prediction tools predicting no significant impact on splicing, although these predictions have yet to be functionally assessed. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 135/120756 (1/894), predominantly in the African cohort, 118/9800 (1/83), which exceeds the estimated maximal expected allele frequency for a pathogenic ATP7B variant of 1/1851. Therefore, suggesting the variant of interest is a common polymorphism found in population(s) of African origin. The variant of interest has not, to our knowledge, been reported in affected individuals via publications. A reputable clinical laboratory cites the variant as "benign." Therefore, taking all available lines of evidence into consideration, the variant of interest has been classified as likely benign until additional information becomes available.
Invitae RCV000302449 SCV000626839 benign Wilson disease 2017-12-27 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.